Rankings
▼
Calendar
REVB Q3 2021 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$20,416
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-8129.35
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$131,320
Balance Sheet
Total Assets
$6M
Total Liabilities
$2M
Stockholders' Equity
$4M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$20,416
$0
—
Operating Income
-$3M
-$868
-350585.1%
Net Income
-$3M
-$868
-350649.3%
← FY 2021
All Quarters
Q4 2021 →